Analysis updated Oct 13, 2026 — scores and signals refreshed daily.
SNDL Inc. (SNDL) stock research. Updated Oct 13, 2026. Q-Score 69/100 — Strong Buy. Fair value, forecast, technicals, and insider activity.
Current Q-Score verdict: Strong Buy (69.0) (grade A). 28 signals analyzed (24 differentiated alt-data).
StoQuant's analysis of SNDL Inc. (SNDL) is refreshed every trading day. The Q-Score combines discounted cash flow valuation, earnings quality, competitive moat, analyst consensus, ML return forecasts, technical momentum and market sentiment into a single 0–100 composite. Insider transactions from SEC Form 4 filings, the Graham intrinsic value estimate and signal coverage are recomputed as new data arrives, so this page always reflects the latest available information.
SNDL stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-07-27 | $1.37 | $1.25 | $1.35 |
| 2026-08-04 | $1.23 | $1.21 | $1.21 |
| 2026-08-12 | $1.30 | $1.25 | $1.26 |
| 2026-08-20 | $1.37 | $1.30 | $1.33 |
| 2026-08-28 | $1.36 | $1.32 | $1.36 |
| 2026-09-08 | $1.46 | $1.40 | $1.44 |
| 2026-09-16 | $1.39 | $1.35 | $1.38 |
| 2026-09-24 | $1.42 | $1.38 | $1.40 |
| 2026-10-02 | $1.29 | $1.24 | $1.24 |
| 2026-10-12 | $1.23 | $1.17 | $1.17 |
| 2026-10-20 | $1.29 | $1.25 | $1.28 |
How SNDL Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| KYTX | Kyverna Therapeutics, Inc. | $375M | — |
| IRD | Opus Genetics, Inc. | $361M | — |
| SY | So-Young International Inc. | $346M | — |
| ASMB | Assembly Biosciences, Inc. | $417M | — |
| CABA | Cabaletta Bio, Inc. | $331M | — |
View all Health Care stocks by valuation and signals →
SNDL Inc. (SNDL) scores Strong Buy (69.0), and the composite conceals a 62-point disagreement between its dimensions. It is strongest on valuation at 78, and weakest on technicals at 20 and analyst consensus at 16. A stock can carry valuation that high while analyst consensus sits at 16; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| valuation | 78 |
| technicals | 20 |
| analyst consensus | 16 |
StoQuant analyzes 28 signals (24 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on SNDL Inc. (SNDL): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
Browse daily research picks • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and IC-weighted signals (live edge on /proof). We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/SNDL"><img src="https://stoquant.com/badge/SNDL.svg" alt="SNDL Inc. (SNDL) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Free StoQuant digest by email. No account needed. See today's research picks.